rvallee
Senior Member (Voting Rights)
Also harms are obviously far more important to look at than benefits, even more so in illnesses that are widely known to be both highly fluctuating but also often relapse.I think they are different. Hence treatments need clinical trials to show effectiveness, but can be withdrawn if there are lots of yellow card reports, ie anecdotes, from individuals of serious side effects.
This is the literal basis of "first do no harm", but it's not in effect for an issue that's been demedicalized. It should be self-evident that people ending up bedbound or far more disabled than they came in, sometimes permanently, consists of harm, no reasonable person would argue otherwise. The problem is that the deterioration itself is denied, because it is "subjective", even though it is far more objective than all the subjective benefits combined, which are conveniently emphasized.